EA201001029A1 - Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления - Google Patents

Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления

Info

Publication number
EA201001029A1
EA201001029A1 EA201001029A EA201001029A EA201001029A1 EA 201001029 A1 EA201001029 A1 EA 201001029A1 EA 201001029 A EA201001029 A EA 201001029A EA 201001029 A EA201001029 A EA 201001029A EA 201001029 A1 EA201001029 A1 EA 201001029A1
Authority
EA
Eurasian Patent Office
Prior art keywords
phenyacoxic
derivatives
acid
inflammation modulators
inflammatory
Prior art date
Application number
EA201001029A
Other languages
English (en)
Inventor
Марк Грилло
Ан-Ронг Ли
Цзивэнь Лю
Джулио С. Медина
Юнли Су
Инцай Ван
Джанан Джона
Алан Аллгайер
Жаклин Милн
Джерри Мёрри
Джозеф Ф. Паяк
Томас Сторц
Original Assignee
Амген Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амген Инк. filed Critical Амген Инк.
Publication of EA201001029A1 publication Critical patent/EA201001029A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Предложены соединения, фармацевтические композиции и способы, которые являются полезными при лечении воспалительных и иммунносвязаных заболеваний и состояний. В особенности изобретение обеспечивает соединения, которые модулируют функцию и/или экспрессию протеинов, вовлеченных в атопические заболевания, воспалительные состояний и рак. Объектом соединения являются производные карбоновой кислоты.
EA201001029A 2007-12-19 2008-12-18 Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления EA201001029A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US843307P 2007-12-19 2007-12-19
PCT/US2008/013833 WO2009085177A1 (en) 2007-12-19 2008-12-18 Phenyl acetic acid derivatives as inflammation modulators

Publications (1)

Publication Number Publication Date
EA201001029A1 true EA201001029A1 (ru) 2011-06-30

Family

ID=40564868

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001029A EA201001029A1 (ru) 2007-12-19 2008-12-18 Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления

Country Status (20)

Country Link
US (1) US8183293B2 (ru)
EP (1) EP2231595B1 (ru)
JP (1) JP5437267B2 (ru)
KR (1) KR20100102668A (ru)
CN (1) CN101903338A (ru)
AR (1) AR071279A1 (ru)
AU (1) AU2008343924B2 (ru)
BR (1) BRPI0821197A2 (ru)
CA (1) CA2707789A1 (ru)
CL (1) CL2008003832A1 (ru)
CO (1) CO6321234A2 (ru)
CR (1) CR11572A (ru)
EA (1) EA201001029A1 (ru)
ES (1) ES2471919T3 (ru)
IL (1) IL206069A0 (ru)
MA (1) MA32013B1 (ru)
PE (1) PE20091526A1 (ru)
TN (1) TN2010000223A1 (ru)
TW (1) TW200940051A (ru)
WO (1) WO2009085177A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
US20140328861A1 (en) 2011-12-16 2014-11-06 Atopix Therapeutics Limited Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
US9974759B2 (en) * 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
EP4420734A2 (en) 2015-02-13 2024-08-28 Institut National de la Santé et de la Recherche Médicale Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
TN2018000322A1 (en) 2016-03-22 2020-01-16 Merck Sharp & Dohme Allosteric modulators of nicotinic acetylcholine receptors
ES2733477T3 (es) 2017-07-04 2019-11-29 Fis Fabbrica Italiana Sintetici Spa Procedimiento eficaz para la preparación de sitagliptina a través de una preparación muy eficaz del intermedio ácido 2,4,5-trifluorofenilacético

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704158D0 (en) 1987-02-23 1987-04-01 Wellcome Found Substituted hydantoin compounds
US5849780A (en) 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
HUT73813A (en) 1993-06-30 1996-09-30 Wellcome Found Anti-athero-sclerotic diaryl compounds, process to prepare them and pharmaceutical compositions contg. them
US5545669A (en) 1994-06-02 1996-08-13 Adams; Jerry L. Anti-inflammatory compounds
DK0799206T3 (da) 1994-12-20 2003-01-27 Hoffmann La Roche Aryl- og heteroaryl-sulfonamidderivater, fremstillingen deraf og anvendelsen deraf som endothelinantagonister
US6008234A (en) 1996-09-12 1999-12-28 Berlex Laboratories, Inc. Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
JP3565864B2 (ja) 1996-09-12 2004-09-15 シエーリング アクチエンゲゼルシヤフト 環式アミノ酸または環式ヒドロキシ酸誘導体により置換されたベンズアミジン誘導体および抗擬固薬としてのこれらの使用
TW523506B (en) 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
JPH11202458A (ja) 1998-01-16 1999-07-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5929250A (en) 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
JP2002512997A (ja) 1998-04-29 2002-05-08 バーテックス ファーマシューティカルズ インコーポレイテッド Ｉｍｐｄｈ酵素のインヒビター
AR023659A1 (es) 1998-09-18 2002-09-04 Vertex Pharma Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
ATE272609T1 (de) 1999-03-01 2004-08-15 Pfizer Prod Inc Oxamsäure und deren derivate als liganden der thyroid-rezeptoren
JP3828364B2 (ja) 1999-03-10 2006-10-04 塩野義製薬株式会社 ［２．２．１］および［３．１．１］ビシクロ骨格を有するｐｇｄ２／ｔｘａ２両受容体拮抗性医薬組成物
JP3486408B2 (ja) 1999-08-23 2004-01-13 株式会社ビー・エム・エル 物質のヒトプロスタグランジンｄ２受容体に対する性質の同定方法
US6531291B1 (en) 1999-11-10 2003-03-11 The Trustees Of Columbia University In The City Of New York Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
EP1255750A1 (en) 2000-02-01 2002-11-13 Millenium Pharmaceuticals, Inc. INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa
US20010047027A1 (en) 2000-04-12 2001-11-29 Marc Labelle Prostaglandin D2 receptor antagonists
US7084136B2 (en) 2000-06-02 2006-08-01 Shionogi & Co., Ltd. Drug composition antagonistic to both PGD2/TXA2 receptors
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
AU2002229611A1 (en) 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
WO2002051805A1 (de) 2000-12-27 2002-07-04 Bayer Aktiengesellschaft Indol-derivate
DE60215000T2 (de) 2001-05-23 2007-08-09 Merck Frosst Canada & Co, Kirkland Dihydropyrroloil[1,2-a]indol- und Tetrahydropyridol[1,2-a]indol-Derivate als Prostaglandin-D2-Rezeptor-Antagonisten
JP4529119B2 (ja) 2001-08-09 2010-08-25 小野薬品工業株式会社 カルボン酸誘導体化合物およびその化合物を有効成分として含有する薬剤
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
WO2003078409A1 (fr) 2002-03-19 2003-09-25 Ono Pharmaceutical Co., Ltd. Composes d'acide carboxylique et medicaments renfermant les composes comme principe actif
AU2003231509A1 (en) 2002-05-16 2003-12-02 Shionogi And Co., Ltd. Compound exhibiting pgd 2 receptor antagonism
AU2003231513A1 (en) 2002-05-16 2003-12-02 Shionogi And Co., Ltd. Pgd2 receptor antagonist
GB2388540A (en) 2002-05-17 2003-11-19 Bayer Ag New use of Ramatroban
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
JP4457017B2 (ja) 2002-12-20 2010-04-28 アムジエン・インコーポレーテツド 喘息及びアレルギー性炎症モジュレーター
WO2005054176A1 (en) 2003-11-25 2005-06-16 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
JP5155171B2 (ja) * 2005-10-06 2013-02-27 アストラゼネカ・アクチエボラーグ 新規化合物
KR20090089868A (ko) * 2006-12-15 2009-08-24 글락소 그룹 리미티드 Ｅｐ４ 수용체 작동제로서 벤즈아미드 유도체
US7960567B2 (en) 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
CA2768492A1 (en) 2009-07-31 2011-02-03 Panmira Pharmaceuticals, Llc Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
SG177736A1 (en) 2009-07-31 2012-02-28 Panmira Pharmaceuticals Llc Dermal formulations of dp2 receptor antagonists

Also Published As

Publication number Publication date
JP5437267B2 (ja) 2014-03-12
AU2008343924A2 (en) 2011-02-17
CL2008003832A1 (es) 2010-03-26
TN2010000223A1 (en) 2011-11-11
KR20100102668A (ko) 2010-09-24
IL206069A0 (en) 2010-11-30
ES2471919T3 (es) 2014-06-27
TW200940051A (en) 2009-10-01
JP2011507847A (ja) 2011-03-10
CO6321234A2 (es) 2011-09-20
PE20091526A1 (es) 2009-11-01
US8183293B2 (en) 2012-05-22
EP2231595A1 (en) 2010-09-29
AU2008343924A1 (en) 2009-07-09
MA32013B1 (fr) 2011-01-03
CR11572A (es) 2010-08-13
BRPI0821197A2 (pt) 2015-06-16
US20090275659A1 (en) 2009-11-05
EP2231595B1 (en) 2014-04-23
AU2008343924B2 (en) 2013-01-17
AR071279A1 (es) 2010-06-09
CA2707789A1 (en) 2009-07-09
WO2009085177A1 (en) 2009-07-09
CN101903338A (zh) 2010-12-01

Similar Documents

Publication Publication Date Title
EP4134364A3 (en) Bromodomain inhibitors
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA200802050A1 (ru) Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов
EA201692166A1 (ru) Гетероциклические ингибиторы глютаминазы
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201300684A1 (ru) Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1
EA201170161A1 (ru) 1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
EA200900819A1 (ru) Хиназолины для ингибирования pdk1
EA201500278A1 (ru) Пиразолилхиназолиновые ингибиторы киназы
EA201300730A1 (ru) Производные индазолилтриазола
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
EA201170832A1 (ru) Пуриновые соединения
ATE495743T1 (de) Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
EA201291099A1 (ru) Новые иммуномодуляторные и противовоспалительные соединения
MA32551B1 (fr) Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires
RS53617B1 (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
BR112013010310A2 (pt) inibidores de acetil-coa carboxilase de lactama n1/n2
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA201001865A1 (ru) Противовоспалительные агенты
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
EA201001029A1 (ru) Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления